Fanzhen Lv

About

Dr. Fanzhen Lv is a pioneering thoracic surgeon whose research centers on advancing minimally invasive surgical techniques for lung cancer, particularly for patients with advanced-stage disease. His major contribution lies in providing high-level evidence from randomized controlled trials (RCTs) that robotic-assisted thoracoscopic surgery (RATS) is not only safe but also offers superior short-term outcomes compared to traditional thoracotomy for clinical N2 stage non-small cell lung cancer (NSCLC). His landmark 2019 RCT (28 citations) first established the safety and short-term efficacy of RATS for this challenging patient group, while his subsequent 2021 multicenter RCT (27 citations) extended these findings with longer follow-up and a larger sample, demonstrating that RATS significantly reduces perioperative complications while achieving comparable long-term survival. This work directly challenges the conventional preference for open surgery in advanced NSCLC, offering patients a less invasive option without compromising oncologic outcomes. Dr. Lv’s rigorous clinical trials have been instrumental in shifting the surgical paradigm, providing robust data that supports the broader adoption of robotic surgery for complex lung cancer cases.

Research Focus

Key Achievements

Top Papers

1. 1
   Robot-assisted thoracoscopic surgery versus thoracotomy for c-N2 stage NSCLC: short-term outcomes of a randomized trial

   28 citations · 2019
2. 2
   Robotic-assisted thoracic surgery reduces perioperative complications and achieves a similar long-term survival profile as posterolateral thoracotomy in clinical N2 stage non-small cell lung cancer patients: a multicenter, randomized, controlled trial

   27 citations · 2021

Key Collaborators

Contact & Links